FDA.reportPublic FDA data

alpha 1-proteinase inhibitor, human 1 MG Injection [Glassia]

RxCUI
1013867
RxNorm name
alpha 1-proteinase inhibitor, human 1 MG Injection [Glassia]
Display name
alpha 1-proteinase inhibitor, human 1 MG Injection [Glassia]
Full name
alpha 1-proteinase inhibitor, human 1 MG Injection [Glassia]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:06

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125325GlassiaAlpha-1-Proteinase Inhibitor (Human)351(a)Rx2026-09-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
83473cbb-48e4-42a2-81b6-4c851423da7bGlassia 1 MG Injection [PSN] · alpha 1-proteinase inhibitor, human 1 MG Injection [Glassia] [SBD] · Glassia 1 MG Injection [SY]331These highlights do not include all the information needed to use GLASSIA safely and effectively. See full prescribing information for GLASSIA. GLASSIA ® (Alpha 1 -Proteinase Inhibitor (Human)) Injection, For Intravenous Use Initial U.S. Approval: 201020251202